768 related articles for article (PubMed ID: 34702349)
61. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
Kwong YL; Chan TSY; Tan D; Kim SJ; Poon LM; Mow B; Khong PL; Loong F; Au-Yeung R; Iqbal J; Phipps C; Tse E
Blood; 2017 Apr; 129(17):2437-2442. PubMed ID: 28188133
[TBL] [Abstract][Full Text] [Related]
62. A Rare Case of Aggressive Disseminated Nasal-Type Epstein-Barr Virus-Positive Extranodal Natural Killer/T-Cell Lymphoma with Bone Marrow Involvement.
Yee AC; Karim FW; Giashuddin SM; Grutman G
Am J Case Rep; 2023 Jun; 24():e939286. PubMed ID: 37384825
[TBL] [Abstract][Full Text] [Related]
63. Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Chaubard S; Marouf A; Lavergne D; Lemonnier F; Rossignol J; Clavert A; Gressin R; Cartron G; Waultier-Rascalou A; Vargaftig J; Salles G; Bachy E; Ghesquières H; Tournilhac O; Chauchet A; Le Gouill S; Damaj G; Fornecker LM; Sibon D; Obéric L; Michot JM; Gaulard P; Hermine O; Couronné L; Jaccard A
Br J Haematol; 2023 May; 201(4):673-681. PubMed ID: 36799516
[TBL] [Abstract][Full Text] [Related]
64. How we treat NK/T-cell lymphomas.
Tse E; Zhao WL; Xiong J; Kwong YL
J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
[TBL] [Abstract][Full Text] [Related]
65. Efficacy of pegaspargase in extra nodal natural killer/T-cell lymphoma nasal type: A case report from China.
Xiong X; Cai Z; Yang J; Shu X
J Cancer Res Ther; 2015; 11(3):665. PubMed ID: 26458696
[TBL] [Abstract][Full Text] [Related]
66. An aggressive primary orbital natural killer/T-cell lymphoma case: poor response to chemotherapy.
Marchino T; Ibáñez N; Prieto S; Novelli S; Szafranska J; Mozos A; Graell X; Buil JA
Ophthalmic Plast Reconstr Surg; 2014; 30(5):e131-4. PubMed ID: 24317101
[TBL] [Abstract][Full Text] [Related]
67. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
[TBL] [Abstract][Full Text] [Related]
68. High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
Ding H; Chang J; Liu LG; Hu D; Zhang WH; Yan Y; Ma LY; Li ZC; Ma YJ; Hao SG; Tao R
Int J Hematol; 2015 Aug; 102(2):181-7. PubMed ID: 25997870
[TBL] [Abstract][Full Text] [Related]
69. Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Kim HJ; Ock CY; Kim TM; Lee SH; Lee JY; Jung SH; Cho YS; Kim M; Keam B; Kim DW; Kim IH; Heo DS
Cancer Res Treat; 2018 Jul; 50(3):670-680. PubMed ID: 28675023
[TBL] [Abstract][Full Text] [Related]
70. "Sandwich" protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study.
Shen CQ; He GQ; Wan Z; Lin C; Yang X; Lu XX; Zhu YP; Gao J; Guo X
Ann Hematol; 2023 Nov; 102(11):3143-3152. PubMed ID: 37486391
[TBL] [Abstract][Full Text] [Related]
71. Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers.
Huang L; Yuan B; Wu H; Chu H; Liu Y; Wu S; Li H; Lu H; Chen H
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):152-158. PubMed ID: 28215935
[TBL] [Abstract][Full Text] [Related]
72. Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.
Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
Medicine (Baltimore); 2019 Dec; 98(49):e18260. PubMed ID: 31804361
[TBL] [Abstract][Full Text] [Related]
73. [Primary testicular NK/T cell lymphoma. Case report and review of literature].
Avilés-Salas A; Heredia-Jara AN; Peña-Carvajalino LF; Chanona-Vilchis JG; Arriaga-Marroquín JÁ; Candelaria M
Rev Med Chil; 2023 Mar; 151(3):381-386. PubMed ID: 38293884
[TBL] [Abstract][Full Text] [Related]
74. Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding.
Althoff A; Bibliowicz M
Cureus; 2017 May; 9(5):e1260. PubMed ID: 28652944
[TBL] [Abstract][Full Text] [Related]
75. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
[TBL] [Abstract][Full Text] [Related]
76. Updating targets for natural killer/T-cell lymphoma immunotherapy.
Xue W; Zhang M
Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
[TBL] [Abstract][Full Text] [Related]
77. Extranodal NK/T-cell lymphoma primarily presenting as two adjacent slowly growing skin nodules with prominent epidermotropism and CD30 expression, a case report and review of literature.
Mohammed A; Dave U; Ms SR; Alomari AK
Dermatol Online J; 2021 Dec; 27(12):. PubMed ID: 35499432
[TBL] [Abstract][Full Text] [Related]
78. A five
Vittayawacharin P; Khuhapinant A
Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
[TBL] [Abstract][Full Text] [Related]
79. Case report: Relapsed/refractory extranodal natural killer/T-cell lymphoma nasal type with extensive central nervous system involvement.
Dapkevičiūtė-Purlienė A; Augustinavičius V; Žučenka A
Pathol Oncol Res; 2022; 28():1610866. PubMed ID: 36699620
[No Abstract] [Full Text] [Related]
80. Primary central nervous system extranodal NK/T cell lymphoma, nasal type, with antecedent hemophagocytic syndrome in a child.
Jiang X; Yin W; Song J; Chen X; Zhao C; Wen F
Pediatr Dev Pathol; 2014; 17(6):482-6. PubMed ID: 25207703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
